Antihypertensive Effect of Clonidine
- 1 February 1971
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 127 (2), 233-237
- https://doi.org/10.1001/archinte.1971.00310140061005
Abstract
A new antihypertensive agent, clonidine hydrochloride, was administered to 27 patients with essential hypertension for periods ranging from 4 to 18 weeks. Use of the drug in maximally tolerated doses of 0.15 to 0.9 mg daily resulted in a statistically significant reduction in average mean blood pressure (approximately 10 mm Hg) in both recumbent and standing positions. The combination of clonidine and hydrochlorothiazide produced greater reduction in supine and standing positions than either drug alone, regardless of which agent was administered first. Addition of clonidine to the regimen of patients treated with guanethidine caused a further reduction of standing, but not recumbent blood pressure. Common side effects were drowsiness, dryness of the mouth, and symptoms related to orthostasis. These side effects prevented utilization of maximally effective doses of clonidine in several patients.Keywords
This publication has 4 references indexed in Scilit:
- Analysis of the cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (Catapres)European Journal of Pharmacology, 1968
- Mechanisms of the pressor and depressor actions of St 155 (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, catapres®)European Journal of Pharmacology, 1968
- Mechanism of Hypotensive Action of 2-(2,6-Dichlorophenylamino)-2-imidazoline Hydrochloride (ST-155) in the CatJournal of Pharmaceutical Sciences, 1968
- The antihypertensive effects of an imidazoline compoundClinical Pharmacology & Therapeutics, 1967